Press release
Head and Neck Cancer Market: A Catalyst for Innovation in Precision Medicine, Minimally Invasive Surgery, and Immunotherapy
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1217
According to the latest research by InsightAce Analytic, the global Head and Neck Cancer market is valued at US$ 2.44 Billion in 2021, and it is expected to reach US$ 9.07 Billion by 2030, with a CAGR of 16.2% during a forecast period of 2023-2031.
Head and neck cancer is caused mainly by squamous cells, which line the mucosal surfaces of the head and neck, including the interior of the mouth, nose, and throat. Head and neck cancers can affect the salivary glands, pharynx, larynx, paranasal sinuses, nasal cavity, and oral cavity. There are approximately 630,000 new cases of head and neck cancer (HNC) each year, making it the sixth most common cancer globally. Squamous cell carcinomas, or HNCs, affect the salivary glands, oral cavity, scalp, and paranasal sinuses in addition to the nasal cavities and paranasal sinuses. The mouth cavity is where cancer most frequently develops and is largely connected with cigarette and alcohol usage.
The main factor driving the head and neck cancer market is the rise in head and neck malignancies. The aging population, substantial financing for oncology research, unmet medical needs, growing market rivalry, improved regulatory framework, the aging population, and rising government support are a few additional factors driving the growth of the global head and neck cancer market. The head and neck cancer sector nevertheless raises worries despite these reasons. The high cost of therapy may hamper market expansion, the drawbacks of present treatments, the lack of healthcare coverage, and the inadequate healthcare systems in low- and middle-income nations. The efficiency of medication development is predicted to rise as scientific and technological developments in R&D and manufacturing processes increase. However, a sizable proportion of clinical trials fall short of expectations. This is a significant barrier to the growth of new companies in the global market for head and neck cancer.
North America is anticipated to be the major contributor to the Head and Neck Cancer market over the forecast years due to the rising incidence of head and neck cancer, rising use of cutting-edge medical technologies, large market player presence, high healthcare costs, and increased knowledge of contemporary cancer treatments. In addition, the Asia Pacific regional market is expected to register significant growth during the estimated period. The need for therapies for treating head and neck cancer is anticipated to increase due to the region's rapidly expanding patient population, which would likely propel the market. Manufacturers should benefit financially from expanding the biopharmaceutical sector and local government initiatives in the coming years.
Major market players operating in the Head and Neck Cancer market include
Advaxis, Inc. (US), Amgen, Inc. (US), AstraZeneca plc (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (Ono Pharmaceutical Co., Ltd.) (Japan), Cel-Sci Corporation (US), Five Prime Therapeutics, Inc. (US), GlaxoSmithKline plc (UK), Incyte Corporation (US), IRX Therapeutics, Inc. (US), MacroGenics, Inc. (US), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer, Inc., Roche Holdings AG (Genentech) (Switzerland), Viracta Therapeutics (US) among others.
Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1217
Recent collaborations and agreements in the market:
• In July 2021, Novartis (Switzerland) partnered with Kura Oncology, Inc., a clinical-stage biopharmaceutical company, to assess the efficacy of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma.
• In June 2021, CEL-SCI Corporation (United States) revealed the results of a 9.5-year pivotal Phase 3 research for its immunotherapy Multikine (Leukocyte Interleukin, Injection) in the treatment of advanced (stages III and IV) primary (previously untreated) squamous cell carcinoma of the head and neck (SCCHN). In a significant head and neck cancer phase 3 study, CEL-Multikine® SCI's Immunotherapy achieved a 14.1% 5-year survival benefit (62.7% vs 48.6%) in the group undergoing surgery plus radiotherapy.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1217
Market Segments
Global Head and Neck Cancer Market, by Products, 2023-2031 (Value US$ Mn)
• Cytotoxic Agents
• Antimetabolites
• Abitrexate/ Mexate/ Folex (methotrexate)
• Hydrea (hydroxyurea)
• Antitubulins
• Taxotere (docetaxel)
• Others (Platinum Agents, Fluoropyrimidines)
• Platinol (cisplatin)
• 5-fluorouracil (5-FU)
• EGFR Inhibitors (mAbs)
• Erbitux (cetuximab)
• Vectibix (panitumumab)
• Theracim/Theraloc (nimotuzumab)
• EGFR Inhibitors (TKIs)
• Tarceva (erlotinib)
• Iressa (gefitinib)
• Tykerb/Tyverb (lapatinib)
• PD1 Inhibitors
• Keytruda (pembrolizumab)
• Opdivo (nivolumab)
• Pipeline Drugs (Late-stage)
• EGFR Inhibitors (mAbs)
• Vectibix (panitumumab)
• PDL1 Inhibitors
• Imfinzi (durvalumab)
• Bavencio (avelumab)
• CTLA4 Inhibitors
• Yervoy (ipilimumab)
• Tremelimumab
Global Head and Neck Cancer Market, by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Head and Neck Cancer Market, by Country, 2023-2031 (Value US$ Mn)
• U.S.
• Canada
Europe Head and Neck Cancer Market, by Country, 2023-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Head and Neck Cancer Market, by Country, 2023-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Head and Neck Cancer Market, by Country, 2023-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Head and Neck Cancer Market, by Country, 2023-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Head and Neck Cancer market
To receive an industry overview and future trends of the Head and Neck Cancer market
To analyze the Head and Neck Cancer market drivers and challenges
To get information on the Head and Neck Cancer market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Head and Neck Cancer market industry
For More Information @ https://www.insightaceanalytic.com/customisation/1217
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Head and Neck Cancer Market: A Catalyst for Innovation in Precision Medicine, Minimally Invasive Surgery, and Immunotherapy here
News-ID: 3530129 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Head
Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs.
Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with…
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps…
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion.
View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/
Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample
A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as…
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops
LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the…
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai.
The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games.
To coincide with the…
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action.
Most recently, each of the KnowledgetoAction…
